AI Breakthrough Could Detect Pancreatic Cancer 3 Years Early, Before Symptoms Even Begin

Pancreatic cancer is among the deadliest forms of cancer, mostly because it is rarely detected early. According to studies, by 2030, it is projected to become the second-leading cause of cancer-related deaths in the United States and among the top ten globally. A major reason is that nearly 85 per cent of cases are diagnosed only after the disease has already spread, making treatment far more difficult. But a new artificial intelligence (AI) tool may soon change that narrative. Experts say pancreatic cancer often develops silently. In its early stages, it produces few or absolutely no symptoms, and tumours may not be visible on standard imaging scans. By the time symptoms like abdominal pain, weight loss, or jaundice appear, the disease is often advanced.

This delay in diagnosis has long been the biggest barrier to improving survival rates. As experts note, detecting the disease when it is still curable has remained a major challenge until now.Also read: From Sculpted to Savage: Ram Charan’s Akhada-Style Workout for Peddi Breaks Fitness Norms

The AI breakthrough: What is REDMOD?

Researchers from the Mayo Clinic and the University of Texas MD Anderson Cancer Center have developed a powerful AI system known as REDMOD, or Radiomics-Based Early Detection Model. Unlike traditional methods that look for visible tumours, REDMOD analyses radiomic patterns, tiny changes in tissue texture and structure within CT scans that are often invisible to the human eye. These subtle signals can appear years before a tumour becomes detectable.

What are the key findings from the study?

The AI model was trained on 969 CT scans and then tested on additional datasets. The results are promising:

• REDMOD detected pancreatic cancer in 73% of cases before diagnosis
• It identified signs of cancer around 16 months earlier than standard detection
• In some instances, it flagged abnormalities over two years in advance
• Human radiologists, by comparison, detected early signs in only 38.9 per cent of cases

This means the AI system nearly doubles early detection rates, offering a significant advantage in identifying the disease sooner.

How AI improves cancer detection

Cancer often begins with genetic mutations that slowly alter how cells grow and divide. These changes can take years to form a detectable tumour. REDMOD’s strength lies in spotting these early, hidden alterations before they evolve into visible cancer. For patients, experts believe this could be life-changing. Detecting pancreatic cancer earlier increases the chances of effective treatment, including surgery and targeted therapies.

Limitations and next steps

While the results are encouraging, the technology is not perfect. In the study, some healthy individuals were incorrectly flagged as high-risk, meaning further testing would be required to confirm diagnosis. Researchers now aim to test REDMOD in larger, more diverse populations, integrate it into real-world clinical workflows, and improve accuracy to reduce false positives. The findings, published in the journal Gut, highlight the potential of AI in shifting healthcare from late-stage diagnosis to early intervention. Scientists say if successfully implemented, REDMOD could revolutionise how pancreatic cancer is detected - turning a disease known for late diagnosis into one that can be caught early. It may also pave the way for similar AI-driven tools across other cancers. The fight against pancreatic cancer has long been limited by late detection. With innovations like REDMOD, there is new hope that technology can bridge this gap. Early detection saves lives, and AI might finally make that possible.